3.1.2021 Urology COViD Didactics - Genomics of Bladder Cancer
2.22.2021 Urology COViD Didactics - Immunotherapy for Bladder Cancer
5.11.2020 Urology COViD Didactics - Epidemiology, Genetics, and Staging of RCC
9.21.2020 Urology COViD Didactics - Paternal Aging and Implications on Male Fertility
4.17.2020 Urology COViD Didactics - BCG Unresponsive Bladder Cancer
ICS Live-The Patients Dilemma: Fears for COVID-19 for Neurogenic Bladder Complications
Optimising the management of non-muscle invasive bladder cancer from diagnosis to cure
Management of Non Muscle Invasive Bladder Cancer Webcast (2021)
Immunotherapy for NMIBC: Emerging and Expanding Indications
Novel Therapies to Non Muscle Invasive Bladder Cancer
2021 West Oncology | Genitourinary Cancers | Latest Updates on Advanced Bladder Cancer
Neoadjuvant Immune Checkpoint Inhibition for Muscle Invasive Bladder Cancer
Focus on Bladder Genetics
Treatment of high risk nMIBC in era of BCG shortage - EMPIRE Urology Lecture Series
Early RC in high risk NMIBC: Is it justified? by Shahrokh SHARIAT
Basic Science in Bladder Cancer: What a Practicing Urologist Needs to Know in 2017
Urowebinar: Is immune therapy changing the way we think about early bladder cancer?
A 43-year-old male with right loin pain and left-sided scrotal swelling; Presentation and Management
Evolving Role of BCG in Non-Muscle Invasive Bladder Cancer-Myths & Facts
Beyond BCG in non-muscle invasive Bladder Cancer
